GGrantIndex
← Leaderboards

Peter J. Snyder

University Of Pennsylvania

$40,848,094
Attributed
$40,848,094
Total exposure
18
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $8.9M · FY200515
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$40,848,094 · 18

By mechanism

U01$33,679,691 · 2
R01$4,653,263 · 2
M01$2,188,001 · 13
T32$327,139 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchHuman SubjectHormone TherapyHuman Therapy EvaluationTestosteroneBone DensityHypogonadismMaleSkeletal Disorder ChemotherapyDrug Screening /EvaluationPlacebosPituitary NeoplasmsSomatotropinRandomizedSerumAffectOsteoporosisVertebral ColumnAreaTesticular DiseasesFallsPlacebo ControlElderly ManCognition

Grant awards (81)

Testerone Trial$1,549,760
U01 · FY2015 · AG · contact PI
The Bone Trial of the Testosterone Trial$477,762
R01 · FY2015 · AG · contact PI
Testerone Trial$1,506,542
U01 · FY2014 · AG · contact PI
The Bone Trial of the Testosterone Trial$566,261
R01 · FY2014 · AG · contact PI
Testerone Trial$3,619,052
U01 · FY2013 · AG · contact PI
The Bone Trial of the Testosterone Trial$524,065
R01 · FY2013 · AG · contact PI
Testerone Trial$5,176,195
U01 · FY2012 · AG · contact PI
The Bone Trial of the Testosterone Trial$599,083
R01 · FY2012 · AG · contact PI
Testosterone Trial$232,513
U01 · FY2012 · AG · contact PI
Testerone Trial$8,111,831
U01 · FY2011 · AG · contact PI
The Bone Trial of the Testosterone Trial$739,401
R01 · FY2011 · AG · contact PI
Testerone Trial$8,369,038
U01 · FY2010 · AG · contact PI
Testerone Trial$165,799
U01 · FY2010 · AG · contact PI
Testerone Trial$104,800
U01 · FY2010 · AG · contact PI
Testerone Trial$3,567,150
U01 · FY2009 · AG · contact PI
Will Testosterone & Growth Hormone Improve Bone Structure$372,103
R01 · FY2008 · AR · contact PI
Planning project for testosterone trials in aging men$476,245
U01 · FY2007 · AG · contact PI
Will Testosterone & Growth Hormone Improve Bone Structure$342,027
R01 · FY2007 · AR · contact PI
Will Testosterone+Growth Hormone Improve Bone Structure$328,437
R01 · FY2006 · AR · contact PI
Planning project for testosterone trials in aging men$700,001
U01 · FY2005 · AG
Will Testosterone+Growth Hormone Improve Bone Structure$333,204
R01 · FY2005 · AR
Planning project for testosterone trials in aging men.$100,765
U01 · FY2005 · AG
EFFECT OF TESTOSTERONE ON TRABECULAR ARCHITECTURE$1,023
M01 · FY2005 · RR
WILL TESTOSTERONE | GROWTH HORMONE IMPROVE BONE STRUCTURE$682
M01 · FY2005 · RR
Will Testosterone /Growth Hormone Improve Bone Structure$370,920
R01 · FY2004 · AR
Effect of Testosterone on Trabecular Architecture$12,429
M01 · FY2004 · RR
Effects of testosterone on trabecular architecture as determined by MRI$9,277
M01 · FY2004 · RR
Somatropin treatment on bone mineral density for adult onset GHD$1,391
M01 · FY2004 · RR
The Effect of Chronic Somatropin Treatment on Bone Mineral Density$1,065
M01 · FY2004 · RR
RESEARCH IN MINERAL AND SKELETAL HOMEOSTASIS$88,249
T32 · FY2003 · AR
RESEARCH IN MINERAL AND SKELETAL HOMEOSTASIS$143,338
T32 · FY2002 · AR
IPSTYL R FOR TREATMENT OF PATIENTS W/ ACROMEGALY$124,146
M01 · FY2002 · RR
IPSTYL R FOR TREATMENT OF DENOVO PATIENTS W/ ACROMEGALY$124,146
M01 · FY2002 · RR
TESTOSTERONE AND GLUCOCORTICOID INDUCED HYPOGONADISM$124,146
M01 · FY2002 · RR
WILL TESTOSTERONE INCREASE BONE MINERAL DENSITY IN ELDERLY MEN?$124,146
M01 · FY2002 · RR
WILL TESTOSTERONE IN HYPOGONADAL MEN INCREASE BONE MINERAL DENSITY?$124,146
M01 · FY2002 · RR
PHASE III SAFETY AND EFFICACY OF TESTOSTERONE GEL IN HYPERGONADAL MEN$124,146
M01 · FY2002 · RR
GONADOTROPH ADENOMAS: PREVALENCE &PHARMACOLOGY$124,146
M01 · FY2002 · RR
EFFECT OF CHRONIC SOMATROPIN TREATMENT ON BONE MINERAL DENSITY$124,146
M01 · FY2002 · RR
IPSTYL R FOR TREATMENT OF DENOVO PATIENTS W/ ACROMEGALY$124,146
M01 · FY2001 · RR
WILL TESTOSTERONE IN HYPOGONADAL MEN INCREASE BONE MINERAL DENSITY?$124,146
M01 · FY2001 · RR
TESTOSTERONE AND GLUCOCORTICOID INDUCED HYPOGONADISM$124,146
M01 · FY2001 · RR
GONADOTROPH ADENOMAS: PREVALENCE &PHARMACOLOGY$124,146
M01 · FY2001 · RR
EFFECT OF CHRONIC SOMATROPIN TREATMENT ON BONE MINERAL DENSITY$124,146
M01 · FY2001 · RR
IPSTYL R FOR TREATMENT OF PATIENTS W/ ACROMEGALY$124,146
M01 · FY2001 · RR
PHASE III SAFETY AND EFFICACY OF TESTOSTERONE GEL IN HYPERGONADAL MEN$124,146
M01 · FY2001 · RR
WILL TESTOSTERONE INCREASE BONE MINERAL DENSITY IN ELDERLY MEN?$124,146
M01 · FY2001 · RR
RESEARCH IN MINERAL AND SKELETAL HOMEOSTASIS$58,150
T32 · FY2001 · AR
TESTOSTERONE AND GLUCOCORTICOID INDUCED HYPOGONADISM$0
M01 · FY2001 · RR
WILL TESTOSTERONE INCREASE BONE MINERAL DENSITY IN ELDERLY MEN?$0
M01 · FY2001 · RR
WILL TESTOSTERONE IN HYPOGONADAL MEN INCREASE BONE MINERAL DENSITY?$0
M01 · FY2001 · RR
PHASE III SAFETY AND EFFICACY OF TESTOSTERONE GEL IN HYPERGONADAL MEN$0
M01 · FY2001 · RR
GONADOTROPH ADENOMAS: PREVALENCE &PHARMACOLOGY$0
M01 · FY2001 · RR
EFFECT OF CHRONIC SOMATROPIN TREATMENT ON BONE MINERAL DENSITY$0
M01 · FY2001 · RR
IPSTYL R FOR TREATMENT OF PATIENTS W/ ACROMEGALY$0
M01 · FY2001 · RR
IPSTYL R FOR TREATMENT OF DENOVO PATIENTS W/ ACROMEGALY$0
M01 · FY2001 · RR
RESEARCH IN MINERAL AND SKELETAL HOMEOSTASIS$37,402
T32 · FY2000 · AR
EFFECT OF CHRONIC SOMATROPIN TREATMENT ON BONE MINERAL DENSITY$25,114
M01 · FY2000 · RR
PHASE III SAFETY AND EFFICACY OF TESTOSTERONE GEL IN HYPERGONADAL MEN$25,114
M01 · FY2000 · RR
WILL TESTOSTERONE IN HYPOGONADAL MEN INCREASE BONE MINERAL DENSITY?$25,114
M01 · FY2000 · RR
IPSTYL R FOR TREATMENT OF PATIENTS W/ ACROMEGALY$25,114
M01 · FY2000 · RR
WILL TESTOSTERONE INCREASE BONE MINERAL DENSITY IN ELDERLY MEN?$25,114
M01 · FY2000 · RR
IPSTYL R FOR TREATMENT OF DENOVO PATIENTS W/ ACROMEGALY$25,114
M01 · FY2000 · RR
GONADOTROPH ADENOMAS: PREVALENCE &PHARMACOLOGY$25,114
M01 · FY2000 · RR
EFFECT OF CHRONIC SOMATROPIN TREATMENT ON BONE MINERAL DENSITY$0
M01 · FY2000 · RR
EFFECT OF CHRONIC SOMATROPIN TREATMENT ON BONE MINERAL DENSITY$0
M01 · FY2000 · RR
GONADOTROPH ADENOMAS: PREVALENCE &PHARMACOLOGY$0
M01 · FY2000 · RR
GONADOTROPH ADENOMAS: PREVALENCE &PHARMACOLOGY$0
M01 · FY2000 · RR
PHASE III SAFETY AND EFFICACY OF TESTOSTERONE GEL IN HYPERGONADAL MEN$0
M01 · FY2000 · RR
PHASE III SAFETY AND EFFICACY OF TESTOSTERONE GEL IN HYPERGONADAL MEN$0
M01 · FY2000 · RR
WILL TESTOSTERONE IN HYPOGONADAL MEN INCREASE BONE MINERAL DENSITY?$0
M01 · FY2000 · RR
WILL TESTOSTERONE IN HYPOGONADAL MEN INCREASE BONE MINERAL DENSITY?$0
M01 · FY2000 · RR
WILL TESTOSTERONE INCREASE BONE MINERAL DENSITY IN ELDERLY MEN?$0
M01 · FY2000 · RR
WILL TESTOSTERONE INCREASE BONE MINERAL DENSITY IN ELDERLY MEN?$0
M01 · FY2000 · RR
TESTOSTERONE AND GLUCOCORTICOID INDUCED HYPOGONADISM$0
M01 · FY2000 · RR
TESTOSTERONE AND GLUCOCORTICOID INDUCED HYPOGONADISM$0
M01 · FY2000 · RR
TESTOSTERONE AND GLUCOCORTICOID INDUCED HYPOGONADISM$0
M01 · FY2000 · RR
IPSTYL R FOR TREATMENT OF DENOVO PATIENTS W/ ACROMEGALY$0
M01 · FY2000 · RR
IPSTYL R FOR TREATMENT OF DENOVO PATIENTS W/ ACROMEGALY$0
M01 · FY2000 · RR
IPSTYL R FOR TREATMENT OF PATIENTS W/ ACROMEGALY$0
M01 · FY2000 · RR
IPSTYL R FOR TREATMENT OF PATIENTS W/ ACROMEGALY$0
M01 · FY2000 · RR